A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
NCT ID: NCT01145664
Last Updated: 2010-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
390 participants
INTERVENTIONAL
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
NCT01182532
Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease
NCT01554930
Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study
NCT01769794
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
NCT01053533
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
NCT02650141
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Western therapy
Western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Herbal concentrate-granules plus western therapy
Herbal concentrate-granules plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Reduning Injection plus western therapy
Reduning Injection plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Herbal concentrate-granules plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Reduning Injection plus western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Western therapy
Intervention time: 7-10 days; Follow-up time: 5 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. not more than 24 hours of occurrence of severe symptoms
3. age of 1-13 years
4. Patients or their guardians agree to participate in this study and signed the informed consent form
Exclusion Criteria
2. Complicated with other serious diseases such as chronic hepatitis, congenital heart disease, acute or chronic nephritis and blood diseases, etc
3. the history of allergies on Chinese medicine
4. the history of mild increase of blood bilirubin hemolysis (or uric bravery former positive) phenomenon
5. using hormonal therapy
6. Attending other clinical studies on hand-foot-mouth disease
7. Patients or their guardians suffering from mental illness
1 Year
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State Administration of Traditional Chinese Medicine of the People's Republic of China
OTHER_GOV
China Academy of Chinese Medical Sciences
OTHER
Beijing University of Chinese Medicine
OTHER
Beijing YouAn Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beijing YouAn Hospital，Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangzhou Women and Children Hospital
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Kaifeng Municipal Children's Hospital
Kaifeng, Henan, China
Hunan Provincial Children's Hospital
Changsha, Hunan, China
Anhui Provincial Children's Hospital
Anhui, , China
Beijing YouAn Hospital，Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yi Xu
Role: primary
Dan Wei
Role: primary
Xi Zhang
Role: primary
Shuangjie Li
Role: primary
Biquan Chen
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Li XH, Li SJ, Xu Y, Wei D, Shi QS, Zhu QX, Yang T, Ding JB, Tian YM, Huang JH, Wang K, Wen T, Zhang X. Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial. Chin J Integr Med. 2017 Dec;23(12):887-892. doi: 10.1007/s11655-016-2504-3. Epub 2016 Jul 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200907001-3
Identifier Type: -
Identifier Source: org_study_id
NCT01314794
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.